Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Myositis
•
Antisynthetase Syndrome
What’s your drug of choice for patients with stable antisynthetase NSIP-ILD and overlap RA (CCP+) with significant polyarthritis as main manifestation?
Related Questions
In a patient with newly diagnosed with antisynthetase syndrome without clinical myositis who presents with organizing pneumonia and improves on high-dose corticosteroids, what factors should guide the selection of long-term immunosuppressive therapy?
What are useful clinical features that help differentiate mechanics hands from other conditions such as hand dermatitis or psoriasis?
What is the most appropriate next step in management for a patient with dermatomyositis who is maintained on methotrexate 25 mg weekly but develops disease flare when prednisone is tapered below 10 mg daily and is unable to receive IVIG?
Do you routinely perform muscle biopsies in patients presenting with the classic symptoms of Inclusion Body Myositis along with positive CN1A antibody?
How do you utilize tools such as MMT8 in clinical practice when evaluating myositis?
Is there a difference in efficacy between steroid-sparing agents like methotrexate, mycophenolate, and azathioprine in the treatment of immune-mediated myopathies?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you approach selecting optimal muscle biopsy site when evaluating a patient for suspected inflammatory myopathy?
How do you envision incorporating CAR-T therapy into your clinical practice?
How do you approach incidental NXP-2 antibody positivity in patients without current clinical evidence of myositis or systemic autoimmune disease?
